{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T05:42:21Z","timestamp":1782538941238,"version":"3.54.5"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100019271","name":"Kyorin Pharmaceutical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019271","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.ejphar.2022.175065","type":"journal-article","created":{"date-parts":[[2022,5,29]],"date-time":"2022-05-29T09:15:03Z","timestamp":1653815703000},"page":"175065","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Pharmacological characterisation of electrocardiogram J-Tpeak interval in conscious Guinea pigs"],"prefix":"10.1016","volume":"927","author":[{"given":"Hisashi","family":"Nogawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiko","family":"Muraki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Kawai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiharu","family":"Kuninishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2022.175065_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.hrthm.2004.09.011","article-title":"Role of transmural dispersion of repolarization in the genesis of drug-induced torsades de pointes","volume":"2","author":"Antzelevitch","year":"2005","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.ejphar.2022.175065_bib2","doi-asserted-by":"crossref","first-page":"873","DOI":"10.3109\/03639045.2012.707209","article-title":"Influence of quercetin on the pharmacokinetics of ranolazine in rats and in vitro models","volume":"39","author":"Babu","year":"2013","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejphar.2022.175065_bib3","first-page":"353","article-title":"An analysis of the time-relations of electrocardiograms","volume":"7","author":"Bazett","year":"1920","journal-title":"Heart"},{"key":"10.1016\/j.ejphar.2022.175065_bib4","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1124\/jpet.112.198887","article-title":"A novel, potent and selective inhibitor of cardiac late sodium current suppresses experimental arrhythmias","volume":"344","author":"Belardinelli","year":"2013","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2022.175065_bib5","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1177\/1091581818813601","article-title":"A proof-of-concept evaluation of JTPc and Tp-Tec as proarrhythmia biomarkers in preclinical species: a retrospective analysis by an HESI-sponsored consortium","volume":"38","author":"Boulay","year":"2019","journal-title":"Int. J. Toxicol."},{"key":"10.1016\/j.ejphar.2022.175065_bib6","doi-asserted-by":"crossref","first-page":"439","DOI":"10.2131\/jts.41.439","article-title":"Electropharmacological effects of amantadine on cardiovascular system assessed with J-Tpeak and Tpeak-Tend analysis in the halothane-anaesthetized beagle dogs","volume":"41","author":"Cao","year":"2016","journal-title":"J. Toxicol. Sci."},{"key":"10.1016\/j.ejphar.2022.175065_bib7","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/0735-1097(95)00234-U","article-title":"Mexiletine antagonizes effects of sotalol on QT interval duration and its proarrhythmic effects in a canine model of torsade de pointes","volume":"26","author":"Ch\u00e9zalviel-Guilbert","year":"1995","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2022.175065_bib9","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.vascn.2016.03.009","article-title":"An evaluation of 30 clinical drugs against the comprehensive in vitro proarrhythmia assay (CiPA) proposed ion channel panel","volume":"81","author":"Crumb","year":"2016","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.ejphar.2022.175065_bib10","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/jcph.1502","article-title":"Evaluation of the effect of 5 QT-positive drugs on the JTpeak interval - an analysis of ECGs from the IQ-CSRC Study","volume":"60","author":"Darpo","year":"2020","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2022.175065_bib11","series-title":"US Department of Health and Human Services, Food and Drug Administration","article-title":"Guidance for Industry: estimating the maximum safe starting dose in initial clinical trials for therapeutics in adult healthy volunteers","author":"Food and Drug Administration","year":"2005"},{"key":"10.1016\/j.ejphar.2022.175065_bib12","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1161\/01.RES.64.5.977","article-title":"Early afterdepolarizations: mechanism of induction and block. A role for L-type Ca2+ current","volume":"64","author":"January","year":"1989","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2022.175065_bib13","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/clpt.2013.238","article-title":"Improving the assessment of heart toxicity for all new drugs through translational regulatory science","volume":"95","author":"Johannesen","year":"2014","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2022.175065_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0166925","article-title":"Automated algorithm for J-tpeak and tpeak-tend assessment of drug-induced proarrhythmia risk","volume":"11","author":"Johannesen","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2022.175065_bib15","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/cpt.205","article-title":"Late sodium current block for drug-induced long QT syndrome: results from a prospective clinical trial","volume":"99","author":"Johannesen","year":"2016","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2022.175065_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.vascn.2019.106606","article-title":"Exposure-response analysis of drug-induced QT interval prolongation in telemetered monkeys for translational prediction to human","volume":"99","author":"Komatsu","year":"2019","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.ejphar.2022.175065_bib17","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1038\/srep02100","article-title":"MICE models: superior to the HERG model in predicting Torsade de Pointes","volume":"3","author":"Kramer","year":"2013","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2022.175065_bib18","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1469-7793.2000.t01-1-00285.x","article-title":"Molecular basis of functional voltage-gated K+ channel diversity in the mammalian myocardium","volume":"525","author":"Nerbonne","year":"2000","journal-title":"J. Physiol."},{"key":"10.1016\/j.ejphar.2022.175065_bib19","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ejphar.2013.10.056","article-title":"Effects of probucol, a typical hERG expression inhibitor, on in vivo QT interval prolongation in conscious dogs","volume":"720","author":"Nogawa","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2022.175065_bib20","doi-asserted-by":"crossref","first-page":"H1023","DOI":"10.1152\/ajpheart.00785.2011","article-title":"Quantitative comparison of cardiac ventricular myocyte electrophysiology and response to drugs in human and nonhuman species","volume":"302","author":"O'Hara","year":"2012","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ejphar.2022.175065_bib21","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0008-6363(02)00846-5","article-title":"Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development","volume":"58","author":"Redfern","year":"2003","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2022.175065_bib22","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.vascn.2016.04.013","article-title":"ECG telemetry in conscious Guinea pigs","volume":"81","author":"Ruppert","year":"2016","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.ejphar.2022.175065_bib23","doi-asserted-by":"crossref","first-page":"547","DOI":"10.2133\/dmpk.10.547","article-title":"Pharmacokinetics of sotalol enantiomers after single and repeated oral administration of sotalol hydrochloride to rats","volume":"10","author":"Shimizu","year":"1995","journal-title":"Drug Metabol. Pharmacokinet."},{"key":"10.1016\/j.ejphar.2022.175065_bib24","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.vascn.2006.04.008","article-title":"Methodological validation of an existing telemetry system for QT evaluation in conscious Guinea pigs","volume":"55","author":"Shiotani","year":"2007","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.ejphar.2022.175065_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.vascn.2021.107085","article-title":"Differentiating multichannel block on the Guinea pig ECG: Use of Tpeak-Tend and J-Tpeak","volume":"111","author":"Skinner","year":"2021","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.ejphar.2022.175065_bib26","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0008-6363(03)00319-5","article-title":"Sex differences in the rate dependence of the T wave descending limb","volume":"58","author":"Smetana","year":"2003","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2022.175065_bib27","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1093\/eurheartj\/ehi312","article-title":"Non-cardiac QTc-prolonging drugs and the risk of sudden cardiac death","volume":"26","author":"Straus","year":"2005","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ejphar.2022.175065_bib29","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.jelectrocard.2017.08.003","article-title":"Electrocardiographic biomarkers to confirm drug's electrophysiological effects used for proarrhythmic risk prediction under CiPA","volume":"50","author":"Vicente","year":"2017","journal-title":"J. Electrocardiol."},{"key":"10.1016\/j.ejphar.2022.175065_bib30","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.001615","article-title":"Comprehensive T wave morphology assessment in a randomized clinical study of dofetilide, quinidine, ranolazine and verapamil","volume":"4","author":"Vicente","year":"2015","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.ejphar.2022.175065_bib31","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/cpt.896","article-title":"Mechanistic model-informed proarrhythmic risk assessment of drugs: review of the \u201cCiPA\u201d initiative and design of a prospective clinical validation study","volume":"103","author":"Vicente","year":"2018","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2022.175065_bib32","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/cpt.1303","article-title":"Assessment of multi-ion channel block in a phase I randomized study design: results of the CiPA Phase I ECG Biomarker Validation Study","volume":"105","author":"Vicente","year":"2019","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2022.175065_bib33","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2131\/jts.44.441","article-title":"Telemetered common marmosets is useful for the assessment of electrocardiogram parameters changes induced by multiple cardiac ion channel inhibitors","volume":"44","author":"Watanabe","year":"2019","journal-title":"J. Toxicol. Sci."},{"key":"10.1016\/j.ejphar.2022.175065_bib34","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1211\/jpp.62.04.0005","article-title":"Effect of Huang-Lian-Jie-Du-Decoction on pharmacokinetics of verapamil in rats","volume":"62","author":"Xie","year":"2010","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejphar.2022.175065_bib35","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1136\/heart.89.11.1363","article-title":"Drug induced QT prolongation and torsades de pointes","volume":"89","author":"Yap","year":"2003","journal-title":"Heart"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299922003260?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299922003260?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T23:07:17Z","timestamp":1757977637000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299922003260"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":33,"alternative-id":["S0014299922003260"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2022.175065","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological characterisation of electrocardiogram J-Tpeak interval in conscious Guinea pigs","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2022.175065","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"175065"}}